You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 24, June 23, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Hyponatremic Encephalopathy in Postmenopausal Women

Association of Therapies With Morbidity and Mortality

J. Carlos Ayus, MD; Allen I. Arieff, MD

JAMA. 1999;281:2299-2304.

Context  Chronic hyponatremia in postmenopausal women is a common clinical problem often viewed as benign. Fluid restriction is usually the recommended therapy, largely because the extent of morbidity is unknown and because it has been postulated that intravenous (IV) sodium chloride may cause brain damage.

Objective  To compare IV sodium chloride with fluid restriction in the treatment of postmenopausal women with chronic symptomatic hyponatremia.

Design  Nonrandomized prospective study.

Setting  Two university medical centers and affiliated community hospitals.

Patients  A total of 53 postmenopausal women with chronic symptomatic hyponatremia (chronic plasma sodium <130 mmol/L in the presence of central nervous system manifestations) treated consecutively from 1988-1997 and followed up for 1 year. The mean (SD) age of the patients was 62 (11) years.

Interventions  The therapeutic interventions were IV sodium chloride before respiratory insufficiency (n=17), IV sodium chloride after respiratory insufficiency (n=22), and fluid restriction only (n=14).

Main Outcome Measures  Morbidity and neurological outcome at 4 months or longer as assessed by cerebral performance category (CPC) in relation to the therapy, initial plasma sodium level, and rate of correction.

Results  Chronic symptomatic hyponatremia (mean [SD] sodium level 111 [12] mmol/L) was present for 5.2 [4.5] days. Death or major morbidity occurred in 44 (83%) of 53 patients, including 10 with orthopedic injury. Twelve patients had hypoxemia (PO2=63 [25] mm Hg) and cerebral edema. Among patients who received IV sodium chloride before respiratory insufficiency, plasma sodium levels were increased by 22 (10) mmol/L in 35 hours and patients had a CPC of 1.0 (normal or slight disability). Among patients who received IV sodium chloride after respiratory insufficiency, plasma sodium levels were increased by 30 (6) mmol/L in 41 hours and patients had a CPC of 3.0 (1.2) (severe disability). Among patients who had fluid restriction only, plasma sodium levels were increased by 3 (2) mmol/L in 41 hours and patients had a CPC of 4.6 (0.7) (4=persistent vegetative state; 5=death). The outcomes did not correlate with either the initial plasma sodium level (r=0.05, P>.12) or the rate of correction (r=0.31, P>.10).

Conclusions  Chronic symptomatic hyponatremia in postmenopausal women can be associated with major morbidity and mortality. Therapy with IV sodium chloride was associated with significantly better outcomes than fluid restriction.


Author Affiliations: Department of Medicine, Baylor College of Medicine, Houston, Tex (Dr Ayus); and Department of Medicine, University of California School of Medicine, San Francisco (Dr Arieff).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Treatment of Hyponatremic Encephalopathy
Steven A. Smith, Richard H. Sterns, Allen I. Arieff, and J. Carlos Ayus
JAMA. 1999;282(24):2298-2299.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Hypoxia Is the Cause of Brain Damage in Hyponatremia
James P. Knochel
JAMA. 1999;281(24):2342-2343.
EXTRACT | FULL TEXT  

June 23/30, 1999
JAMA. 1999;281(24):2403-2404.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyponatremia in Preterm Neonates: Not a Benign Condition
Moritz and Ayus
Pediatrics 2009;124:e1014-e1016.
FULL TEXT  

Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia
Ayus et al.
Am. J. Physiol. Renal Physiol. 2008;295:F619-F624.
ABSTRACT | FULL TEXT  

Mild hyponatremia and risk of fracture in the ambulatory elderly
Gankam Kengne et al.
QJM 2008;101:583-588.
ABSTRACT | FULL TEXT  

Hypertonic Saline for Hyponatremia: Risk of Inadvertent Overcorrection
Mohmand et al.
CJASN 2007;2:1110-1117.
ABSTRACT | FULL TEXT  

The Adrogue-Madias Formula Revisited
Berl
CJASN 2007;2:1098-1099.
FULL TEXT  

The Syndrome of Inappropriate Antidiuresis
Ellison and Berl
NEJM 2007;356:2064-2072.
FULL TEXT  

New agents for managing hyponatremia in hospitalized patients
Munger
Am J Health Syst Pharm 2007;64:253-265.
ABSTRACT | FULL TEXT  

Disorders of sodium balance.
Reynolds et al.
BMJ 2006;332:702-705.
FULL TEXT  

Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management
Hoorn et al.
Nephrol Dial Transplant 2006;21:70-76.
ABSTRACT | FULL TEXT  

Hyponatremia in Marathon Runners
Peate et al.
NEJM 2005;353:427-428.
FULL TEXT  

Therapeutic Effects of Tolvaptan, a Potent, Selective Nonpeptide Vasopressin V2 Receptor Antagonist, in Rats with Acute and Chronic Severe Hyponatremia
Miyazaki et al.
Endocrinology 2005;146:3037-3043.
ABSTRACT | FULL TEXT  

Salt and water: a simple approach to hyponatremia
Yeates et al.
CMAJ 2004;170:365-369.
ABSTRACT | FULL TEXT  

The pathophysiology and treatment of hyponatraemic encephalopathy: an update
Moritz and Ayus
Nephrol Dial Transplant 2003;18:2486-2491.
FULL TEXT  

Lesson of the week: Fatal dysnatraemia caused by elective colonoscopy
Ayus et al.
BMJ 2003;326:382-384.
FULL TEXT  

Disorders of Water Metabolism in Children: Hyponatremia and Hypernatremia
Moritz and Ayus
Pediatr. Rev. 2002;23:371-380.
FULL TEXT  

Na-K-ATPase activity decreases with aging in female rat brain synaptosomes
Fraser and Arieff
Am. J. Physiol. Renal Physiol. 2001;281:F674-F678.
ABSTRACT | FULL TEXT  

Vasopressin V2 receptor antagonists
Wong and Verbalis
Cardiovasc Res 2001;51:391-402.
ABSTRACT | FULL TEXT  

Close Association of Urinary Excretion of Aquaporin-2 with Appropriate and Inappropriate Arginine Vasopressin-Dependent Antidiuresis in Hyponatremia in Elderly Subjects
Ishikawa et al.
J. Clin. Endocrinol. Metab. 2001;86:1665-1671.
ABSTRACT | FULL TEXT  

Noncardiogenic Pulmonary Edema in Marathon Runners
Ayus and Arieff
ANN INTERN MED 2000;133:1011-1011.
FULL TEXT  

Hyponatremia
Arieff et al.
NEJM 2000;343:886-888.
FULL TEXT  

Hyponatremia, Cerebral Edema, and Noncardiogenic Pulmonary Edema in Marathon Runners
Ayus et al.
ANN INTERN MED 2000;132:711-714.
ABSTRACT | FULL TEXT  

Drug induced syndrome of inappropriate antidiuretic hormone secretion
KASHYAP and KASHYAP
Postgrad. Med. J. 2000;76:318b-318.
FULL TEXT  

Treatment of Hyponatremic Encephalopathy
Smith et al.
JAMA 1999;282:2298-2299.
FULL TEXT  

Children are another group at risk of hyponatraemia perioperatively
Bohn
BMJ 1999;319:1269-1269.
FULL TEXT  

Saline Therapy Indicated for Chronic Hyponatremic Encephalopathy
JWatch Emergency Med. 1999;1999:21-21.
FULL TEXT  

Hypoxia Is the Cause of Brain Damage in Hyponatremia
Knochel
JAMA 1999;281:2342-2343.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.